Astral shares in focus on demerger news but JPMorgan downgrades; check price targets
Published on: June 29, 2026, 7:46 a.m. | Source: CNBC TV18
Another brokerage firm CLSA said the demerger is unlikely to have a meaningful impact on the stock in the near term, adding that sustained growth and margin improvement in the chemicals business will be the key drivers for any future rerating.
